IRVINE, Calif. (AP) _ Endologix Inc. (ELGX) on Thursday reported a loss of $23.9 million in its second quarter.

The Irvine, California-based company said it had a loss of 28 cents per share. Losses, adjusted for non-recurring costs, came to 18 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.

The medical device company posted revenue of $44.7 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $44.4 million.

Endologix expects a full-year loss of $1.12 to $1.04 per share, with revenue in the range of $145 million to $155 million.

In the final minutes of trading on Thursday, the company's shares hit $4.72. A year ago, they were trading at $4.29.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ELGX at https://www.zacks.com/ap/ELGX